Clinical Trial Detail

NCT ID NCT03720678
Title A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Gastrointestinal (GI) Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Arcus Biosciences, Inc.
Indications

stomach cancer

colorectal cancer

esophageal cancer

Therapies

AB928 + Fluorouracil + Leucovorin + Oxaliplatin

Age Groups: adult senior

No variant requirements are available.